Can the effect of drugs be estimated in observational studies?

被引：0

作者：

Skovlund, Eva ^{[1
,2
]}

机构：

[1] NTNU, Inst Samfunnsmed & Sykepleie, Med Stat, Trondheim, Norway

[2] Folkehelseinstituttet, Oslo, Norway

来源：

TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2021年 / 141卷 / 03期

关键词：

PROPENSITY SCORE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：268 / 268

页数：1

共 50 条

[21] EVALUATION OF ESTIMATORS OF TREATMENT EFFECT IN OBSERVATIONAL STUDIES
Faries, D. E.
Lipkovich, I
Kadziola, Z.
VALUE IN HEALTH, 2014, 17 (07) : A585 - A586
[22] The Hawthorne effect in observational studies: Threat or opportunity?
Mostafazadeh-Bora, Mostafa
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (04): : 491 - 491
[23] NICE AND THE CANCER DRUGS FUND - CAN OBSERVATIONAL EVIDENCE INFORM FUNDING DECISIONS IN ONCOLOGY?
Walsh, S.
Liu, L. W.
Macaulay, R.
VALUE IN HEALTH, 2018, 21 : S66 - S66
[24] Commentary: Can we facilitate the ethical approval of international observational studies?
Cuttini, Marina
Saracci, Rodolfo
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2009, 38 (04) : 1108 - 1109
[25] Commentary: Can observational studies provide suitable evidence for spine interventions?
Rihn, Jeffrey A.
SPINE JOURNAL, 2012, 12 (04): : 349 - 350
[26] Observational post-marketing safety studies of biologic drugs in patients with rheumatoid arthritis (RA) - Can structured analysis and reporting improve comparability?
Dixon, William G.
Askling, Johan
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S28 - S29
[27] TRANSPLANT DRUGS EFFECT ON APPEARANCE CAN CAUSE NONCOMPLIANCE
HELWIG, D
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1987, 137 (06) : 538 - 538
[28] CAN MARKET POWER BE ESTIMATED
HYDE, CE
PERLOFF, JM
REVIEW OF INDUSTRIAL ORGANIZATION, 1995, 10 (04) : 465 - 485
[29] CAN MONOPSONY POWER BE ESTIMATED
HYDE, CE
PERLOFF, JM
AMERICAN JOURNAL OF AGRICULTURAL ECONOMICS, 1994, 76 (05) : 1151 - 1155
[30] A MiniReview of the Use of Hospital-based Databases in Observational Inpatient Studies of Drugs
Larsen, Michael D.
Cars, Thomas
Hallas, Jesper
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (01) : 13 - 18

← 1 2 3 4 5 →